Livzon Pharmaceutical Group (SZSE:000513) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Livzon Pharmaceutical Group Change In Receivables?

Livzon Pharmaceutical Group's change in receivables for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Livzon Pharmaceutical Group's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Livzon Pharmaceutical Group's change in receivables for the fiscal year that ended in Dec. 2023 was ¥466 Mil. It means Livzon Pharmaceutical Group's Accounts Receivable declined by ¥466 Mil from Dec. 2022 to Dec. 2023 .

Livzon Pharmaceutical Group's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥2,067 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Livzon Pharmaceutical Group's Days Sales Outstanding for the three months ended in Mar. 2024 was 58.17.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Livzon Pharmaceutical Group's liquidation value for the three months ended in Mar. 2024 was ¥4,039 Mil.

Livzon Pharmaceutical Group Change In Receivables Historical Data

The historical data trend for Livzon Pharmaceutical Group's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Livzon Pharmaceutical Group Change In Receivables Chart

Livzon Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-81.11

-491.93

-664.68

-660.45

466.29

Livzon Pharmaceutical Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Livzon Pharmaceutical Group Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Livzon Pharmaceutical Group (SZSE:000513) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Livzon Pharmaceutical Group's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	2067.187	/	3242.815	*	91
=	58.17

2. In Ben Graham's calculation of liquidation value, Livzon Pharmaceutical Group's accounts receivable are only considered to be worth 75% of book value:

Livzon Pharmaceutical Group's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	11231.003	-	9750.195	+	0.75 * 2067.187	+	0.5 * 2015.39
=	4,039

Livzon Pharmaceutical Group Change In Receivables Related Terms

Thank you for viewing the detailed overview of Livzon Pharmaceutical Group's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Livzon Pharmaceutical Group (SZSE:000513) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Livzon Pharmaceutical Group Inc (SZSE:000513) » Definitions » Change In Receivables

Traded in Other Exchanges

01513:Hong Kong LP6:Germany

Address

38 Chuangye North Road, Headquarters Building, Jinwan District, Guangdong Province, Zhuhai, CHN, 519090

Website

https://www.livzon.com.cn

Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment which is pharmaceutical manufacturing.

Livzon Pharmaceutical Group (SZSE:000513) Headlines

No Headlines